Skip to main content
Premium Trial:

Request an Annual Quote

Complete Genomics Kicks off Competition to Build Analysis Tools for Its Data


Complete Genomics has launched a competition aimed at encouraging the scientific community to develop software that can analyze data from its proprietary sequencing platform.

Participants in the contest, dubbed the Complete Genomics Data Analysis Grant Program, will compete to win whole-genome sequencing for eight genomes at no charge.

Specifically, the company is looking for "innovative and unique" software, scripts, methods, workflows, or other resources used for downstream analysis of its datasets, with the MasterVar or Var file as the starting point.

Each entry must include an abstract and a complete program application. The deadline for submissions is Dec. 2.

A panel of judges, comprised of Complete Genomics' commercial and academic clients, will select eight entries from among the submissions and notify winners by Dec. 16.

Following the notification, winners are expected to send their genomes to Complete Genomics for sequencing by Jan. 31, 2012.

The successful methods will be made publicly available on Complete Genomics' User Community website.

Last year, Illumina launched a similar contest, dubbed the Illumina Data Excellence Award, or iDEA, challenge to encourage the scientific community to develop creative visualization and data analysis techniques for interpreting next-generation sequence data (BI 6/18/2011).

Illumina announced the winners of its iDEA challenge in June this year (BI 7/1/2011).

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.